The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Editorials

Transferability of data between different drug-eluting stents

EuroIntervention 2009;5:527-531. DOI: 10.4244/EIJV5I5A85

1. Department of Interventional Cardiology, Thoraxcentre, Erasmus MC, Rotterdam, The Netherlands; 2. Cardiology Practice and Hospital, Munich, Germany
The introduction of drug-eluting stents (DES) for the treatment of coronary artery disease has considerably influenced the market size and growth rates for coronary stents. Companies are continuously striving to develop stents that are the safest and most effective with the goal of being market leaders. Since a considerable number of stents have been developed to date, and head-to-head comparisons in medical literature indicate the ones with the best results, it is no surprise that last generation DES systems tend to be an iterative progression from the previous successful generation. As a result, regulatory bodies including the Food and Drug ...

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article

PCR and Singapore LIVE join forces: 1+1>3

Latest news